|Dr. Javier S. Burgos Ph.D.||Chief Exec. Officer||N/A||N/A||N/A|
|Dr. Antonio Sánchez Torres||Chief Financial Officer||N/A||N/A||N/A|
|Dr. Soraya Santana Martínez||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. James Webb||Chief Commercial Officer||N/A||N/A||N/A|
|Mr. Enrique Lahuerta Traver||Sec.||N/A||N/A||N/A|
Neuron Bio, S.A. develops biotechnology solutions for pharmaceutical and oleo chemical industry in Spain. It operates through Pharma, Diagnostic, and Services divisions. The Pharma division discovers and develops compounds for the prevention and treatment of neurodegenerative diseases primarily for Alzheimers disease. The diagnostic division develops tools and biomarkers for the diagnosis of human diseases primarily for the central nervous system. The Services division develops research projects in the pharmaceutical, biotechnological, agro-food, and animal health areas for public institutions and companies, as well as offers consultancy services. The company was founded in 2005 and is headquartered in Granada, Spain.
El ISS Governance QualityScore de Neuron Bio, S.A., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.